Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use

Marco Proietti; Irene Marzona; Tommaso Vannini; Mauro Tettamanti; Ida Fortino; Luca Merlino; Stefania Basili; Pier Mannuccio Mannucci; Giuseppe Boriani; Professor Gregory Lip; Maria Carla Roncaglioni; Alessandro Nobili

doi:10.1016/j.mayocp.2019.06.012

Related publications

Article2021

Relationship between multimorbidity and outcomes in atrial fibrillation

Marco Proietti, María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Vanessa Roldán, Inmaculada Roldán Rabadán, Javier Muñiz, Ángel Cequier, Vicente Bertoméu, Lina Badimón, Manuel Anguita, Professor Gregory Lip, Francisco Marı́n

Article2018

P3475Relationship between age and use of oral anticoagulant drugs in european atrial fibrillation patients: the EORP-AF general long-term registry

Giuseppe Boriani, Marco Proietti, C Laroche, Igor Diemberger, C Rheinert, E Serdechnaya, Erdem Diker, Aldo P. Maggioni, Professor Gregory Lip

Article2022

Drug Interactions Affecting Oral Anticoagulant Use

Philip L. Mar, Rakesh Gopinathannair, Brooke Gengler, Mina K. Chung, A. Matamala Pérez, Jonathan W. Dukes, Michael D. Ezekowitz, Dhanunjaya Lakkireddy, Professor Gregory Lip, Mike Miletello, Peter A. Noseworthy, James A. Reiffel, James E. Tisdale, Brian Olshansky

Article2022

Oral Anticoagulant Use for Patients with Atrial Fibrillation with Concomitant Anemia and/or Thrombocytopenia

Yung‐Hsin Yeh, Yi‐Hsin Chan, Shao‐Wei Chen, Shang‐Hung Chang, Chunli Wang, Chi‐Tai Kuo, Professor Gregory Lip, Shih‐Ann Chen, Tze‐Fan Chao

Article2025

Oral anticoagulant therapy for patients with atrial fibrillation on long‐term dialysis: A network meta‐analysis of 137,574 patients

Yao Du, Yan-Mei Zeng, Sixin Xu, Qiwei Shen, Jinzhu Hu, Professor Gregory Lip